Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
Bio-Milliardenmarkt: Steht Organto vor der Neubewertung?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
164 Leser
Artikel bewerten:
(1)

The Language Group Announces Secure and Compliant On-Demand Healthcare Translation Platform Fetch is Now Patent-Protected

VIRGINIA BEACH, VA / ACCESS Newswire / February 17, 2026 / The Language Group (TLG), a leader in language services and technology-enabled solutions, today announced that Fetch, its on-demand healthcare translation platform, is now patent protected. Designed to address language access as a patient safety, compliance, and equity imperative, Fetch brings together people, process, and technology to simplify how clinically critical translations are requested, delivered, and embedded into real-world healthcare workflows by the US Patent and Trademark Office (USPTO).

On-demand healthcare translation platforms must balance speed, accuracy, and compliance in high-risk clinical environments. Fetch delivers secure, human-in-the-loop translations designed to support patient safety, regulatory requirements, and clear patient communication.

Built specifically for healthcare environments, Fetch provides fast, on-demand, clinically reviewed translations of discharge summaries and written patient communications, helping organizations reduce communication risk while meeting strict regulatory and security requirements. Rather than relying on automation alone, Fetch combines AI-assisted translation with qualified human review, ensuring accuracy, context, and patient comprehension at one of the most critical transition points in care.

"Fetch exists because healthcare organizations needed a responsible alternative to AI-only translation," said Giovanni Donatelli, Founder and CEO of The Language Group. "We built Fetch to reflect the reality of clinical communication, where accuracy, accountability, and trust matter as much as speed. Protecting this workflow ensures we can continue delivering language access that supports patient safety, regulatory confidence, and equitable care."

Unlike point solutions that prioritize efficiency at the expense of reliability, Fetch operationalizes a human-in-the-loop translation model, embedding professional linguistic review directly into the workflow without slowing down care delivery. This approach aligns with growing industry consensus that fully automated translation is insufficient for high-risk clinical content, where even minor errors can result in confusion, non-adherence, or adverse outcomes.

"Fetch wasn't built overnight," said Rolf Hecken, Global VP of Tech at The Language Group. "This workflow represents more than five years of careful development, informed by over 25 years of experience in language services. Every element, from PHI handling and compliance controls to linguistic validation, was designed to meet the realities of healthcare delivery at scale."

Fetch supports healthcare organizations' obligations under HIPAA, Section 1557 of the Affordable Care Act, Title VI, and Joint Commission language access standards, delivering secure, audited translations directly within existing clinical systems. By improving patient understanding and reducing preventable communication failures, Fetch helps organizations strengthen outcomes while minimizing regulatory and operational risk.

For more information about Fetch and The Language Group, visit: https://thelanguagegroup.com/fetch/

About The Language Group

Founded in 1999 and headquartered in Virginia Beach, Virginia, The Language Group (TLG) is an award-winning language solutions company providing healthcare translation and interpretation services. With a global talent network and offices in Europe and the US, TLG combines more than a century of senior management expertise with innovative technology and deep cultural understanding to help organizations communicate with confidence in any language.

For more information on Fetch, visit https://thelanguagegroup.com/fetch/.

Contact Information

Kaile Dills
Marketing Specialist
757-431-9004
marketing@thelanguagegroup.com

SOURCE: The Language Group



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/the-language-group-announces-secure-and-compliant-on-demand-healthcar-1137651

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.